Načítá se...
Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains
Targeting bromodomains (BRDs) of the bromo-and-extra-terminal (BET) family offers opportunities for therapeutic intervention in cancer and other diseases. Here, we profile the interactomes of BRD2, BRD3, BRD4, and BRDT following treatment with the pan-BET BRD inhibitor JQ1, revealing broad rewiring...
Uloženo v:
| Vydáno v: | Mol Cell |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Cell Press
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6375729/ https://ncbi.nlm.nih.gov/pubmed/30554943 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molcel.2018.11.006 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|